Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ethanol Ablation Therapy Drives Immune-Mediated Antitumor Effects in Murine Breast Cancer Models

Cancers(2022)10.3390/cancers14194669Source: DataRank Database

Ethanol Ablation Therapy Drives Immune-Mediated Antitumor Effects in Murine Breast Cancer Models is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.47)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Adam M. Swartz,Erika Chelales ORCID,Lauren Y. Sheu ORCID,Brian T. Crouch ORCID,Nirmala Ramanujam ORCID

Live enrichment

PubMed:36230591 PMC:PMC9564135 OpenAlex:https://openalex.org/W4297151155

North Carolina Biotechnology Center, Biotechnology Innovation Grant

Grant: 1R21CA241205-01

North Carolina Biotechnology Center, Biotechnology Innovation Grant

Grant: 1R01CA239268-01

Novel see and treat strategies for cervical cancer prevention in low-resource settings

North Carolina Biotechnology Center

Grant: Biotechnology Innovation Grant

North Carolina Biotechnology Center, Biotechnology Innovation Grant

FWCI

0.47

Citation Percentile

0.6%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2072-6694/14/19/4669/pdf?version=1664109526

publisherhttps://www.mdpi.com/2072-6694/14/19/4669/pdf?version=1664109526

publisherhttps://www.mdpi.com/2072-6694/14/19/4669/pdf

journalhttps://doi.org/10.3390/cancers14194669

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36230591

Fields of Study

Cancer Immunotherapy and BiomarkersImmune cells in cancerCancer Cells and Metastasis0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Cancer researchMedicineBreast cancerPaclitaxelCD8AblationImmune systemTriple-negative breast cancerCytotoxic T cellCancerPathologyInternal medicineImmunologyBiologyImmunomodulationTumor MicroenvironmentTumor AblationLow-resource SettingsMyeloid Derived Supressor CellsArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being